Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Brain Neoplasms × Lomustine × Clear all

Phase

Phase 3 8 Phase 2 7 Phase 1 4 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 4 Recurrence 2 Astrocytoma 2 Oligodendroglioma 1 Glioma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

Gefitinib 2 trofosfamide 1 tozuleristide 1 Thiotepa 1 Temozolomide 1 Sunitinib 1 Magnetic Resonance Spectroscopy 1 Lomustine 1 Etoposide 1 Erlotinib Hydrochloride 1 Cholecalciferol 1 Carboplatin 1 Bevacizumab 1 AZD3759 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03025893 2021-04-19

STELLAR

Amsterdam UMC, location VUmc

Phase 2/3 Unknown

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡